Julia Chapman

2.0k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Julia Chapman is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Julia Chapman has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Julia Chapman's work include Ovarian cancer diagnosis and treatment (4 papers), Vitamin C and Antioxidants Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Julia Chapman is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Vitamin C and Antioxidants Research (3 papers) and Cell Adhesion Molecules Research (3 papers). Julia Chapman collaborates with scholars based in United States, United Kingdom and Canada. Julia Chapman's co-authors include Jeanne Drisko, Verda J. Hunter, Mark Levine, Qi Chen, Yan Ma, Kishore Polireddy, Naresh Kumar, Ira Horowitz, Jonathan S. Berek and J.T. Thigpen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Julia Chapman

26 papers receiving 1.4k citations

Hit Papers

High-Dose Parenteral Ascorbate Enhanced Chemosensitivity ... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Chapman United States 17 422 322 291 250 241 26 1.5k
Raimond Wong Canada 22 326 0.8× 126 0.4× 155 0.5× 393 1.6× 106 0.4× 46 1.8k
Ken Y. Lin United States 16 531 1.3× 57 0.2× 80 0.3× 300 1.2× 117 0.5× 32 1.8k
Yi Jiang China 27 895 2.1× 135 0.4× 116 0.4× 468 1.9× 65 0.3× 156 2.3k
J.A. Gevers Leuven Netherlands 27 523 1.2× 229 0.7× 134 0.5× 139 0.6× 20 0.1× 69 2.4k
Jing Xiong China 24 677 1.6× 55 0.2× 187 0.6× 260 1.0× 40 0.2× 92 1.6k
Xiaowen Chen China 18 630 1.5× 31 0.1× 111 0.4× 174 0.7× 91 0.4× 83 1.4k
Ting Yang China 19 586 1.4× 38 0.1× 73 0.3× 175 0.7× 63 0.3× 60 1.6k
Bruno Baudin France 24 647 1.5× 87 0.3× 62 0.2× 110 0.4× 66 0.3× 80 1.9k
Mani Menon United States 15 338 0.8× 58 0.2× 87 0.3× 125 0.5× 34 0.1× 39 975
Barry Hoffman Canada 18 519 1.2× 32 0.1× 83 0.3× 545 2.2× 157 0.7× 30 1.5k

Countries citing papers authored by Julia Chapman

Since Specialization
Citations

This map shows the geographic impact of Julia Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Chapman more than expected).

Fields of papers citing papers by Julia Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Chapman. The network helps show where Julia Chapman may publish in the future.

Co-authorship network of co-authors of Julia Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Chapman. A scholar is included among the top collaborators of Julia Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Chapman. Julia Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jung‐Min, Richard G. Moore, Sharad Ghamande, et al.. (2022). Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial. Clinical Cancer Research. 28(19). 4186–4193. 33 indexed citations
2.
Jewell, Andrea, et al.. (2020). Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas. The American Journal of Surgery. 221(4). 712–717. 11 indexed citations
3.
Wei, Jun S., Jennifer Li, Shuguang Zhu, et al.. (2017). MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer. Journal of Ovarian Research. 10(1). 33–33. 49 indexed citations
4.
Grauer, Dennis, et al.. (2016). Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors. Thrombosis Research. 147. 104–107. 2 indexed citations
5.
Chapman, Julia, et al.. (2013). On the spot! Peer validation of BP measurement competence. Nursing Management. 44(9). 22–24. 7 indexed citations
6.
Tawfik, Ossama, et al.. (2010). Cutaneous Metastasis of Ovarian Carcinoma With Shadow Cells Mimicking a Primary Pilomatrical Neoplasm. American Journal of Dermatopathology. 32(5). 500–504. 21 indexed citations
7.
Fleming, Gini F., Michael W. Sill, Kathleen M. Darcy, et al.. (2009). Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 116(1). 15–20. 200 indexed citations
8.
Chu, Wenjiang, Julia Chapman, Diane L. Persons, & Fang Fan. (2004). Twin pregnancy with partial hydatidiform mole and coexistent fetus.. Archives of Pathology & Laboratory Medicine. 128(11). 1305–6. 15 indexed citations
9.
Drisko, Jeanne, Julia Chapman, & Verda J. Hunter. (2003). The use of antioxidant therapies during chemotherapy. Gynecologic Oncology. 88(3). 434–439. 84 indexed citations
10.
Yin, Chun, Julia Chapman, & Ossama Tawfik. (2003). Invasive Mucinous (Colloid) Adenocarcinoma of Ectopic Breast Tissue in the Vulva: A Case Report. The Breast Journal. 9(2). 113–115. 31 indexed citations
11.
Drisko, Jeanne, Julia Chapman, & Verda J. Hunter. (2003). The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer. Journal of the American College of Nutrition. 22(2). 118–123. 106 indexed citations
12.
Rothenberg, Mace L., Sharon P. Wilczynski, Edward V. Hannigan, et al.. (2001). Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326). Gynecologic Oncology. 82(2). 317–322. 28 indexed citations
13.
Keefe, Kristen A., Michael J. Schell, Casey Brewer, et al.. (2001). A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.. PubMed. 10(10). 1029–35. 41 indexed citations
15.
Lü, Di, et al.. (1999). Altered Expression of CD44 and Variant Isoforms in Human Adenocarcinoma of the Endocervix during Progression. Gynecologic Oncology. 75(1). 84–90. 15 indexed citations
16.
Kumar, Naresh, et al.. (1998). Vascular injuries in total knee arthroplasty. The Journal of Arthroplasty. 13(2). 211–216. 83 indexed citations
17.
Chapman, Julia, et al.. (1996). Estrogen replacement in surgical stage I and II endometrial cancer survivors. American Journal of Obstetrics and Gynecology. 175(5). 1195–1200. 98 indexed citations
18.
Monk, Bradley J., Julia Chapman, Gary A. Johnson, et al.. (1994). Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer. American Journal of Obstetrics and Gynecology. 171(5). 1193–1198. 27 indexed citations
19.
Chapman, Julia, Yona Tadir, Bruce J. Tromberg, et al.. (1993). Effect of administration route and estrogen manipulation on endometrial uptake of Photofrin porfimer sodium. American Journal of Obstetrics and Gynecology. 168(2). 685–692. 12 indexed citations
20.
McGuinness, Diane, et al.. (1990). Sex differences in incidental recall for words and pictures. Learning and Individual Differences. 2(3). 263–285. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026